EODData

MEMBERSHIP REGISTER LOG IN

FRA, R5XA: ACELRX PHARMACEUT. DL-01

21 Jul 2026
LAST:

1.110

CHANGE:
 0.02		OPEN:
1.110		HIGH:
1.110		ASK:
0.000		VOLUME:
0
CHG(%):
1.77		PREV:
1.130		LOW:
1.110		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Jul 261.1101.1101.1101.1100
20 Jul 261.1301.1301.1301.1300
17 Jul 261.1401.1401.1401.1400
16 Jul 261.2301.2301.2301.2300
15 Jul 261.2001.2001.2001.2000
14 Jul 261.2201.2201.2201.2200
13 Jul 261.2401.2401.2401.2400
10 Jul 261.1601.1601.1601.1600
09 Jul 261.0701.0701.0701.0700
08 Jul 261.0101.0101.0101.0100

PROFILE

Name:ACELRX PHARMACEUT. DL-01
About:Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Sector:Healthcare
Address:1850 Gateway Drive, San Mateo, CA, United States, 94404
Website:https://talphera.com
ISIN:US00444T2096

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:0.17 
PEG Ratio:0.00 
Price to Sales:60,203.59 
Price to Book:3.59 
Operating Margin:-14,516.00 
Return on Assets:-0.40 
Return on Equity:-1.18 
Revenue:876 
Shares:20.5M 
Market Cap:22.76M 

TECHNICAL INDICATORS

MA5:1.164.7%
MA10:1.153.7%
MA20:1.037.6%
MA50:0.8432.2%
MA100:0.7745.1%
MA200:0.8531.3%
STO9:23.53
STO14:61.76
RSI14:69.16 
WPR14:-38.24
MTM14:0.21
ROC14:0.23 
ATR:0.04 
Week High:1.2310.8%
Week Low:1.110.0%
Month High:1.2411.7%
Month Low:0.8331.3%
Year High:1.2411.7%
Year Low:0.30275.0%

RECENT SPLITS

Date Ratio
26 Oct 20221-20